BRET-based RAS biosensors that show a novel small molecule is an inhibitor of RAS-effector protein-protein interactions
The RAS family of proteins is amongst the most highly mutated in human cancers and has so far eluded drug therapy. Currently, much effort is being made to discover mutant RAS inhibitors and in vitro screening for RAS-binding drugs must be followed by cell-based assays. Here, we have developed a robu...
Главные авторы: | Bery, N, Cruz-Migoni, A, Bataille, C, Quevedo, C, Tulmin, H, Miller, A, Russell, A, Phillips, S, Carr, S, Rabbitts, T |
---|---|
Формат: | Journal article |
Язык: | English |
Опубликовано: |
eLife Sciences Publications
2018
|
Схожие документы
-
BRET-based RAS biosensors that show a novel small molecule is an inhibitor of RAS-effector protein-protein interactions
по: Nicolas Bery, и др.
Опубликовано: (2018-07-01) -
Correction: BRET-based RAS biosensors that show a novel small molecule is an inhibitor of RAS-effector protein-protein interactions
по: Nicolas Bery, и др.
Опубликовано: (2018-08-01) -
Small molecule inhibitors of RAS-effector protein interactions derived using an intracellular antibody fragment
по: Quevedo, C, и др.
Опубликовано: (2018) -
Structure-based development of new RAS-effector inhibitors from a combination of active and inactive RAS-binding compounds
по: Cruz-Migoni, A, и др.
Опубликовано: (2019) -
Bioluminescence Resonance Energy Transfer 2 (BRET2)‐based RAS biosensors to characterize RAS inhibitors
по: Bery, N, и др.
Опубликовано: (2019)